Page last updated: 2024-10-26

fenbufen and Pancreatitis

fenbufen has been researched along with Pancreatitis in 1 studies

fenbufen: structure; RN given refers to parent cpd

Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.

Research Excerpts

ExcerptRelevanceReference
"Severe acute pancreatitis (SAP) is an extremely dangerous disease with high mortality, which is associated with inflammatory response and acinar cell death."6.44Fenbufen Alleviates Severe Acute Pancreatitis by Suppressing Caspase-1/Caspase-11-mediated Pyroptosis in Mice. ( Bao, J; Chen, J; Cheng, Z; Guo, X; Jiang, W; Li, K; Shen, J; Shen, S; Wan, R; Wang, C; Xiao, W; Zong, G, 2024)
"Severe acute pancreatitis (SAP) is an extremely dangerous disease with high mortality, which is associated with inflammatory response and acinar cell death."2.44Fenbufen Alleviates Severe Acute Pancreatitis by Suppressing Caspase-1/Caspase-11-mediated Pyroptosis in Mice. ( Bao, J; Chen, J; Cheng, Z; Guo, X; Jiang, W; Li, K; Shen, J; Shen, S; Wan, R; Wang, C; Xiao, W; Zong, G, 2024)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shen, S1
Xiao, W1
Jiang, W1
Li, K1
Guo, X1
Zong, G1
Wang, C1
Bao, J1
Chen, J1
Cheng, Z1
Shen, J1
Wan, R1

Other Studies

1 other study available for fenbufen and Pancreatitis

ArticleYear
Fenbufen Alleviates Severe Acute Pancreatitis by Suppressing Caspase-1/Caspase-11-mediated Pyroptosis in Mice.
    Current molecular pharmacology, 2024, Volume: 17, Issue:1

    Topics: Acute Disease; Amylases; Animals; Caspase 1; Caspases; Ceruletide; Female; Lipase; Lipopolysaccharid

2024